Related Experiment Video
Updated: May 27, 2026

Ambulatory ECG Recording in Mice
Published on: May 27, 2010
Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever
Udi Nussinovitch1, Benjamin Volovitz, Moshe Nussinovitch
1Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel.
Background:
A scarcity of data exists relating to the effect of amyloidosis of Familial Mediterranean fever (FMF) on the autonomic nervous system. Our aim was to further investigate the presence of dysautonomia in FMF-AA amyloidosis, using a comparative case series design.
Material And Methods:
The study group consisted of 40 patients with FMF: 20 without co-morbidities or amyloidosis and 20 in various stages of renal amyloidosis. Time domain and power spectral analyses of heart rate dynamics were performed according to accepted procedures. Findings were compared with 20 healthy control subjects.
Results:
No statistically significant differences were found in any of the studied heart rate variability (HRV) parameters between patients with uncomplicated FMF and controls. In contrast, patients with progressive amyloidosis (post renal transplantation or on dialysis) had significantly lower HRV parameters compared to control subjects (i.e. mean low frequency power spectral components 104.30 ms² vs. 172.09 ms², p <0.05, mean standard deviation of all normal RR intervals 32.27 ms vs. 51.51 ms, p <0.05, mean HRV triangular index 9.08 vs. 15.82, p <0.05). The adjusted odds ratio was 14.5 (95%CI 1.21-165.03, p = 0.04) for HRV triangular index lower than 12.2 in the progressive amyloidosis group, 41.24 (95%CI 1.81-938.68, p = 0.02) for low frequency power spectral components values lower than 142.35 ms², and 12.67 (95%CI 1.04-153.96, p = 0.04) for standard deviation of all normal RR intervals values lower than 40.15?ms.
Conclusion:
Amyloidosis of FMF, particularly at a progressive stage, is associated with HRV abnormalities suggestive of the presence of autonomic nervous system dysfunction.
Insights
Familial Mediterranean fever amyloidosis, especially in advanced stages, is linked to autonomic nervous system dysfunction. This is evidenced by abnormal heart rate variability (HRV) in patients with progressive FMF-AA amyloidosis.
Area of Science:
- Cardiology
- Nephrology
- Neurology
Background:
- Familial Mediterranean fever (FMF) can lead to amyloidosis, affecting organs like the kidneys.
- The impact of FMF-associated amyloidosis on the autonomic nervous system (ANS) is not well-documented.
- Autonomic dysfunction (dysautonomia) may play a role in the progression of FMF-AA amyloidosis.
Purpose of the Study:
- To investigate the presence and extent of autonomic nervous system dysfunction in patients with FMF-AA amyloidosis.
- To compare heart rate variability (HRV) parameters between FMF patients with and without amyloidosis, and healthy controls.
- To identify potential correlations between HRV abnormalities and the stage of FMF-associated amyloidosis.
Main Methods:
- A comparative case series design was employed.
- The study included 40 patients with FMF, divided into 20 without comorbidities/amyloidosis and 20 with renal amyloidosis.
- Heart rate dynamics were analyzed using time domain and power spectral analyses, with comparisons to 20 healthy controls.
Main Results:
- Patients with uncomplicated FMF showed no significant HRV differences compared to controls.
- Patients with progressive amyloidosis (on dialysis or post-transplant) exhibited significantly reduced HRV parameters (e.g., lower low frequency power, lower standard deviation of RR intervals, lower HRV triangular index) compared to controls.
- Abnormal HRV parameters were strongly associated with progressive amyloidosis, with odds ratios ranging from 12.67 to 41.24.
Conclusions:
- Amyloidosis associated with Familial Mediterranean fever, particularly in its progressive stages, is linked to significant autonomic nervous system dysfunction.
- Heart rate variability abnormalities serve as indicators of dysautonomia in FMF-AA amyloidosis.
- These findings highlight the importance of assessing ANS function in FMF patients with amyloidosis.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mechanism of Cardiac Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
